Investor Relations

H-CYTE is a medical biosciences company focused in the field of regenerative medicine. H-CYTE’s mission is to become a leader in next-generation, cellular therapeutics for the treatment of chronic health conditions.

Investor Contact Information

Company

H-CYTE, Inc
201 E Kennedy Blvd
Suite 700
Tampa, FL 33602

Investor Relations

LR Advisors LLC
Jason Assad
President
2020 Stone Meadow Way
Cumming, GA 30041
T: (678) 570-6791
jassad@HCYTE.com

Transfer Agent

Interwest Transfer Co., Inc.
1981 Murray Holiday Rd
Ste 100
Salt Lake City, UT 84117
T: (801) 272-9294

Investor Relations

Latest News

H-CYTE Announces Publication of Additional Data that Further Supports Efficacy of Innovative PRP-PBMC Treatment Aimed at Helping to Improve Overall Lung Health

H-CYTE Announces Publication of Positive Real-World Data Relating to the Use of Innovative Treatment (PRP-PBMC) Aimed at Helping Improve Overall Lung Health

Robert Greif named Chief Executive Officer of H-CYTE

Latest Financial Results

Q1 2021

Latest Annual Filing

Report Links

Sign Up For Email Alerts

Company Overview

Investor Contact Information

Company

Investor Relations

Transfer Agent